Ng, B. G., Eklund, E. A., Shiryaev, S. A., Dong, Y. Y., Abbott, M. A., Asteggiano, C. G., . . . Papazoglu, G. M. (2020). Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestions. Web
Citación estilo ChicagoNg, Bobby G., et al. Predominant and Novel De Novo Variants in 29 Individuals With ALG13 Deficiency: Clinical Description, Biomarker Status, Biochemical Analysis, and Treatment Suggestions. 2020.
Cita MLANg, Bobby G., et al. Predominant and Novel De Novo Variants in 29 Individuals With ALG13 Deficiency: Clinical Description, Biomarker Status, Biochemical Analysis, and Treatment Suggestions. 2020.
Precaución: Estas citas no son 100% exactas.